Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 120, Issue 2, Pages 187-194
Publisher
Wiley
Online
2016-09-01
DOI
10.1111/bcpt.12664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study
- (2016) Christel Renoux et al. BMC Cardiovascular Disorders
- Data Resource Profile: Danish online drug use statistics (MEDSTAT)
- (2016) Morten Schmidt et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
- (2015) Christopher B. Granger et al. AMERICAN HEART JOURNAL
- Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and BleedingCLINICAL PERSPECTIVE
- (2015) Peter Brønnum Nielsen et al. CIRCULATION
- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
- (2015) A. Gorst-Rasmussen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants
- (2015) Franziska Michalski et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation
- (2015) Franziska Ebertz et al. THROMBOSIS AND HAEMOSTASIS
- Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
- (2015) Laila Staerk et al. BMJ-British Medical Journal
- Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
- (2015) Laila Staerk et al. BMJ-British Medical Journal
- The Danish National Patient Registry: a review of content, data quality, and research potential
- (2015) Morten Schmidt et al. Clinical Epidemiology
- Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study
- (2014) Torben Bjerregaard Larsen et al. AMERICAN JOURNAL OF MEDICINE
- Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation
- (2014) Torben Bjerregaard Larsen et al. AMERICAN JOURNAL OF MEDICINE
- Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care - results from the Dresden NOAC registry
- (2014) Jan Beyer-Westendorf et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
- (2014) J. B. Olesen et al. EUROPACE
- The Danish Civil Registration System as a tool in epidemiology
- (2014) Morten Schmidt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study
- (2014) A. Pottegård et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: Comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens
- (2014) Rui Providência et al. THROMBOSIS RESEARCH
- Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
- (2013) Manesh R. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
- (2011) J. B. OLESEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Danish National Prescription Registry
- (2011) Helle Wallach Kildemoes et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving
- (2011) Lau Caspar Thygesen et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started